RxNorm Semantic Concepts Index - 521
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "521".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 5210 | Hemopexin | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 5210 | Hemopexin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5210 | Hemopexin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 52101 | Cyclobenzaprine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 52101 | Cyclobenzaprine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52101 | Cyclobenzaprine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 52103 | Lithium acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 52103 | Lithium acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 52103 | Lithium acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 52105 | lithium citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 52105 | lithium citrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52105 | lithium citrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 52105 | lithium citrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52105 | lithium citrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 52106 | lithium gluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 52106 | lithium gluconate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 52106 | lithium gluconate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 52110 | Lithostat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 52147 | Locoid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 52151 | Lodoxamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 52151 | Lodoxamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52151 | Lodoxamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 52151 | Lodoxamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52151 | Lodoxamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 5216 | Hemosiderin | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 5216 | Hemosiderin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5216 | Hemosiderin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 52162 | lonazolac calcium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 52165 | Beta-hydroxyacyl-CoA dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 52165 | Beta-hydroxyacyl-CoA dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 52165 | Beta-hydroxyacyl-CoA dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 52165 | Beta-hydroxyacyl-CoA dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 52172 | Ciclopirox ethanolamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 52172 | Ciclopirox ethanolamine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 52172 | Ciclopirox ethanolamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52172 | Ciclopirox ethanolamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 52172 | Ciclopirox ethanolamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 52175 | Losartan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 52175 | Losartan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52175 | Losartan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 52175 | Losartan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52175 | Losartan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 52177 | loteprednol etabonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 52177 | loteprednol etabonate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 52177 | loteprednol etabonate | Full form of descriptor (FN) | YES |